ClinConnect ClinConnect Logo
Search / Trial NCT05119868

Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring

Launched by FEDERICO II UNIVERSITY · Nov 3, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how following the Mediterranean Diet during pregnancy may help reduce the risk of allergies in children by the age of two. The Mediterranean Diet is known for being healthy and includes plenty of fruits, vegetables, whole grains, and healthy fats. Researchers believe that what mothers eat while pregnant can influence their child's immune system and possibly prevent allergies, which are becoming more common today.

To participate in this study, women aged 20 to 35 who are in their first trimester of pregnancy and have a baby at risk for allergies may be eligible. However, certain health conditions, such as infections, autoimmune diseases, or a vegan diet, could exclude someone from joining. Participants will be asked to follow the Mediterranean Diet and will be monitored throughout their pregnancy to see if this dietary change affects allergy development in their children. This research aims to provide valuable insights into preventing allergies in future generations.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • - healthy women (aged 20-35 years), at first trimester of pregnancy, of at risk for atopy baby
  • Exclusion Criteria:
  • concomitant presence of infections;
  • concomitant presence of malignancies;
  • concomitant presence of major gastrointestinal malformations;
  • concomitant presence of immunodeficiencies;
  • concomitant presence of autoimmune diseases;
  • concomitant presence of chronic inflammatory bowel diseases;
  • concomitant presence of functional gastrointestinal disorders;
  • concomitant presence of celiac disease;
  • history of abdominal surgery with gastrointestinal resection;
  • concomitant presence of neuropsychiatric disorders;
  • concomitant presence of central nervous system disorders;
  • vegan diet;
  • twin pregnancy;
  • concomitant presence of genetic disorders;
  • concomitant presence of metabolic disorders.

About Federico Ii University

Federico II University, located in Naples, Italy, is a prestigious academic institution with a strong emphasis on advanced research and clinical innovation. As a clinical trial sponsor, the university is committed to fostering the development of novel therapeutic interventions and enhancing patient care through rigorous scientific inquiry. With a multidisciplinary approach, Federico II University collaborates with healthcare professionals, researchers, and industry partners to conduct high-quality clinical trials that adhere to ethical standards and regulatory requirements. Its dedication to improving health outcomes is reflected in its robust research programs and commitment to translating scientific findings into clinical practice.

Locations

Naples, , Italy

Naples, , Italy

Patients applied

0 patients applied

Trial Officials

Roberto Berni Canani

Principal Investigator

Department of Traslational Medical Science at University of Naples Federico II

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials